ICICI Prudential Nifty Pharma Index Fund Regular Growth
EquityIndex Funds
17.28
0.17(0.98%)
NAV as on 11 Dec, 2025
CAGR
20.31%
- AUM (Crs.)94.13
- Expense Ratio0.98 %
- Sharpe Ratio / Category Average-
- Standard Deviation / Category Average-
- Beta / Category Average-
- Portfolio Turnover / Category Average85.99 / 44.68
- Top 5 Stocks Wt.58.34
- Top 10 Stocks Wt.78.97
- Top 3 Sectors Wt.99.98
- Investment StyleLarge Growth
- Morningstar Rating
Portfolio
Asset Allocation
Weightage by Market Cap
Concentration
- No. of Stocks--
- Avg. Market Cap--
- Top 10 Stocks--
- Top 5 Stocks--
- Top 3 Sectors--
View Holdings
Fundamentals
| Measures | Fund | Category Average |
|---|
Risk Metrics
Peers
1Y3Y5Y10Y
| Mutual Fund | AUM (cr.) | 3YReturns |
|---|
Holdings
Stocks
Sector
About
- Fund Manager(s)Check HistoryNishit Patel, Ashwini Shinde
- Launch Date15 Dec, 2022
- BenchmarkS&P BSE 500
Objective
The objective of the Scheme is to invest in companies whose securities are included in Nifty Pharma Index and subject to tracking errors, to endeavor to achieve the returns of the above index. This would be done by investing in all the stocks comprising the Nifty Pharma Index in the same weightage that they represent in Nifty Pharma Index. However, there is no assurance or guarantee that the investment objective of the scheme shall be achieved.
Riskometer
More Funds From
| Fund Name | Morningstar Rating | AUM (cr.) | 1Y Returns | 3Y Returns | 5Y Returns |
|---|